IPHA
Closed
Innate Pharma
1.845
+0.030 (+1.65%)
Last Update: 01 Jul 2025 23:01:00
Yesterday: 1.815
Day's Range: 1.7701 - 1.845
Send
sign up or login to leave a comment!
When Written:
3.18
Innate Pharma is a French biotechnology company that specializes in the development of immunotherapy drugs to treat cancer and other diseases. The company was founded in 1999 and is headquartered in Marseille, France. Innate Pharma's drug development pipeline includes both monoclonal antibodies and small molecule drugs that target the immune system to fight cancer. The company's lead product candidate is called lirilumab, which is being developed for the treatment of various types of cancer. Innate Pharma has collaborations with several pharmaceutical companies, including Bristol-Myers Squibb, AstraZeneca, and Sanofi. The company is publicly traded on the Euronext Paris stock exchange under the ticker symbol IPH.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








